CALIDI BIOTHERAPEUTICS, INC.

Insiders Calidi Biotherapeutics, Inc.

Equities

CLDI

US3207031010

Delayed Nyse Other stock markets 07:32:52 16/05/2024 pm IST			5-day change	1st Jan Change
0.2397 ^USD	+2.61%		+3.32%	-84.13%

16/04	Calidi Biotherapeutics Prices $6.1 Million Offering	MT
21/03	H.C. Wainwright Lowers Price Target on Calidi Biotherapeutics to $2 From $11, Maintains Buy Rating	MT

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Calidi Biotherapeutics, Inc. Announces Scientific and Medical Advisory Board Appointments	08/01	CI
Calidi Biotherapeutics Announces Directorate Changes	12/12	CI
Calidi Biotherapeutics, Inc. Announces the Resignation of Alfonso Zulueta as A Director, Including His Position on Audit Committee of the Board	06/12	CI
Calidi Biotherapeutics, Inc. Announces Key Leadership Promotions and New Board Appointment	01/11	CI
Calidi Biotherapeutics Names Andrew Jackson as Chief Financial Officer	30/23/30	MT
Calidi Biotherapeutics, Inc. Announces Resignation of Tony Kalajian as Interim Chief Financial Officer	28/23/28	CI
Calidi Biotherapeutics, Inc. Announces Resignation of Tony Kalajian as Chief Accounting Officer	28/23/28	CI
Calidi Biotherapeutics, Inc. Appoints Alan R. Stewart as the Class I Director	25/23/25	CI
Calidi Biotherapeutics, Inc. Announces the Resignation of Dr. Heehyoung Lee, Including All Her Positions on the Committees of the Board	17/23/17	CI
First Light Acquisition Group's co-CEO Bill Weber Steps Down	28/22/28	MT
First Light Acquisition Group, Inc. Announces Resignation of Bill Weber as Co-Chiefexecutive Officer, Director and Chairman of the Board of Directors	27/22/27	CI
First Light Acquisition Group, Inc. Announces Executive Changes	17/22/17	CI
First Light Acquisition Group Shareholders Approve Merger Date Extension; Tom Vecchiolla Named Co-CEO	16/22/16	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.

BENEFIT NOW